跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fuzotral - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Fuzotral
Approved
STANDARD
Fuzotral
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
78e1b40cd7604723
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
78e1b40cd7604723
Drug Approval Philippines Name
Fuzotral
Product Name
Fuzotral
Registration Number
DRP-13700
Brand Name
Fuzotral
Generic Name
Alfuzosin Hydrochloride
Dosage Form
Extended-Release Tablet
Dosage Strength
10 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Trader
India
Distributor
Ambica International Corporation
Issuance Date
29 March 2023
Expiry Date
29 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
78e1b40cd7604723
Type
Standard
Back to Philippines FDA Approvals